Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-Based Compensation - Grants (Details)

v3.25.0.1
Stock-Based Compensation - Grants (Details) - $ / shares
shares in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]      
Granted 0 0 0
Exercised 0    
Series A common stock      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at beginning of period 23,530    
Forfeited/Cancelled (4,299)    
Outstanding at end of period 19,231 23,530  
Exercisable at end of period 19,173    
WAEP      
Outstanding at beginning of period $ 7.72    
Forfeited/Cancelled 10.55    
Outstanding at end of period 7.09 $ 7.72  
Exercisable at end of period $ 7.08    
Additional disclosures      
Weighted average remaining life - options outstanding 1 year 10 months 24 days    
Weighted average remaining life - options exercisable 1 year 10 months 24 days    
Series B common stock      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at beginning of period 723    
Forfeited/Cancelled (316)    
Outstanding at end of period 407 723  
Exercisable at end of period 407    
WAEP      
Outstanding at beginning of period $ 12.35    
Forfeited/Cancelled 11.59    
Outstanding at end of period 12.95 $ 12.35  
Exercisable at end of period $ 12.95    
Additional disclosures      
Weighted average remaining life - options outstanding 3 months 18 days    
Weighted average remaining life - options exercisable 3 months 18 days